Sanyal A J, Hirsch J I, Moore E W
Department of Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298.
Am J Physiol. 1994 Feb;266(2 Pt 1):G318-23. doi: 10.1152/ajpgi.1994.266.2.G318.
The role of bile salts in intestinal Fe absorption has not previously been defined. We have recently shown that bile salts having cholanic ring 7 alpha-OH and/or 12 alpha-OH groups bind Fe2+ with high affinity at premicellar concentrations and also produce a two-to threefold enhancement in Fe2+ uptake from perfused intestinal segments in vivo. However, the physiological relevance of these observations for Fe2+ absorption was not known. To study this, we examined the effects of a single dose of taurocholate (TC) administered with 59Fe-FeSO4 in reversing iron malabsorption induced by bile duct ligation. Fe absorption from three 0.5-mg doses of 59Fe-FeSO4 was measured from five groups of six adult Sprague-Dawley rats each: group 1, before and after bile duct ligation and subsequent administration of 59Fe-FeSO4 + TC test dose; group 2, before and after bile duct ligation followed by a third dose of Fe alone; group 3, before and after bile duct ligation followed by a third dose of Fe+taurodehydrocholate (TDHC); group 4, sham laparotomy; and group 5, nonoperated controls where Fe absorption was measured from three doses of 59Fe-FeSO4 at the same time intervals as group 1. Absorption was measured, using whole body counting, after achievement of steady-state counts after each Fe dose. Mean percentage absorption from dose 1 (baseline) was 35.33 +/- 4.6% (SE). No significant differences between any groups were noted. In nonoperated controls (group 4), Fe absorption was virtually identical after all three doses. Also, hematocrit did not change in any of the 30 animals.(ABSTRACT TRUNCATED AT 250 WORDS)
胆汁盐在肠道铁吸收中的作用此前尚未明确。我们最近发现,具有胆烷环7α-羟基和/或12α-羟基基团的胆汁盐在亚微胶粒浓度下能与Fe2+高亲和力结合,并且在体内还能使灌注肠段对Fe2+的摄取提高两到三倍。然而,这些观察结果与Fe2+吸收的生理相关性尚不清楚。为了研究这一点,我们检测了单剂量牛磺胆酸盐(TC)与59Fe-FeSO4一起给药对逆转胆管结扎所致铁吸收不良的影响。从五组每组六只成年Sprague-Dawley大鼠中测量了三次0.5毫克剂量的59Fe-FeSO4的铁吸收情况:第1组,胆管结扎前后以及随后给予59Fe-FeSO4 + TC试验剂量;第2组,胆管结扎前后,随后单独给予第三剂铁;第3组,胆管结扎前后,随后给予第三剂铁+牛磺去氢胆酸盐(TDHC);第4组,假手术;第5组,未手术对照,在与第1组相同的时间间隔测量三次59Fe-FeSO4剂量的铁吸收情况。在每次铁剂量达到稳态计数后,使用全身计数法测量吸收情况。第1剂(基线)的平均吸收百分比为35.33±4.6%(标准误)。未观察到任何组之间有显著差异。在未手术对照(第4组)中,所有三剂后的铁吸收几乎相同。此外,30只动物中的任何一只的血细胞比容都没有变化。(摘要截短至250字)